BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Inamura K. Prostatic cancers: understanding their molecular pathology and the 2016 WHO classification. Oncotarget 2018;9:14723-37. [PMID: 29581876 DOI: 10.18632/oncotarget.24515] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Rayhan MA, Hossen MS, Niloy MS, Bhuiyan MH, Paul S, Shakil MS. Biopolymer and Biomaterial Conjugated Iron Oxide Nanomaterials as Prostate Cancer Theranostic Agents: A Comprehensive Review. Symmetry 2021;13:974. [DOI: 10.3390/sym13060974] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
2 Schillaci O, Scimeca M, Trivigno D, Chiaravalloti A, Facchetti S, Anemona L, Bonfiglio R, Santeusanio G, Tancredi V, Bonanno E, Urbano N, Mauriello A. Prostate cancer and inflammation: A new molecular imaging challenge in the era of personalized medicine. Nucl Med Biol 2019;68-69:66-79. [PMID: 30770226 DOI: 10.1016/j.nucmedbio.2019.01.003] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
3 Sidhu SK, Mohd Sharin MF, Mohd Ghani KA, Mohd Zainuddin SA, Azizan N, Hayati F. Primary prostatic signet ring cell carcinoma in elderly with obstructive uropathy: a case report. Afr J Urol 2022;28. [DOI: 10.1186/s12301-022-00283-w] [Reference Citation Analysis]
4 Sandomenico A, Ruvo M. Targeting Nodal and Cripto-1: Perspectives Inside Dual Potential Theranostic Cancer Biomarkers. Curr Med Chem 2019;26:1994-2050. [PMID: 30207211 DOI: 10.2174/0929867325666180912104707] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
5 Aggarwal S, Mitra S, Dewan A, Durga G. Carcinosarcoma prostate with osteosarcomatous differentiation: a rare de novo presentation. BMJ Case Rep 2019;12:e230116. [PMID: 31196973 DOI: 10.1136/bcr-2019-230116] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
6 Flynn L, Barr MP, Baird AM, Smyth P, Casey OM, Blackshields G, Greene J, Pennington SR, Hams E, Fallon PG, O'Leary J, Sheils O, Finn SP. Prostate cancer-derived holoclones: a novel and effective model for evaluating cancer stemness. Sci Rep 2020;10:11329. [PMID: 32647229 DOI: 10.1038/s41598-020-68187-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Abdulrahman A, Eckstein M, Jung R, Guzman J, Weigelt K, Serrero G, Yue B, Geppert C, Stöhr R, Hartmann A, Wullich B, Wach S, Taubert H, Lieb V. Expression of GP88 (Progranulin) Protein Is an Independent Prognostic Factor in Prostate Cancer Patients. Cancers (Basel) 2019;11:E2029. [PMID: 31888257 DOI: 10.3390/cancers11122029] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
8 König P, Eckstein M, Jung R, Abdulrahman A, Guzman J, Weigelt K, Serrero G, Hayashi J, Geppert C, Stöhr R, Hartmann A, Wullich B, Wach S, Taubert H, Lieb V. Expression of AR-V7 (Androgen Receptor Variant 7) Protein in Granular Cytoplasmic Structures Is an Independent Prognostic Factor in Prostate Cancer Patients. Cancers (Basel) 2020;12:E2639. [PMID: 32947898 DOI: 10.3390/cancers12092639] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
9 De Silva F, Alcorn J. A Tale of Two Cancers: A Current Concise Overview of Breast and Prostate Cancer. Cancers (Basel) 2022;14:2954. [PMID: 35740617 DOI: 10.3390/cancers14122954] [Reference Citation Analysis]
10 Saranyutanon S, Deshmukh SK, Dasgupta S, Pai S, Singh S, Singh AP. Cellular and Molecular Progression of Prostate Cancer: Models for Basic and Preclinical Research. Cancers (Basel) 2020;12:E2651. [PMID: 32957478 DOI: 10.3390/cancers12092651] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
11 Yong C, Moose DL, Bannick N, Gutierrez WR, Vanneste M, Svensson R, Breheny P, Brown JA, Dodd RD, Cohen MB, Henry MD. Locally invasive, castrate-resistant prostate cancer in a Pten/Trp53 double knockout mouse model of prostate cancer monitored with non-invasive bioluminescent imaging. PLoS One 2020;15:e0232807. [PMID: 32986721 DOI: 10.1371/journal.pone.0232807] [Reference Citation Analysis]
12 Lieb V, Abdulrahman A, Weigelt K, Hauch S, Gombert M, Guzman J, Bellut L, Goebell PJ, Stöhr R, Hartmann A, Wullich B, Taubert H, Wach S. Cell-Free DNA Variant Sequencing Using Plasma and AR-V7 Testing of Circulating Tumor Cells in Prostate Cancer Patients. Cells 2021;10:3223. [PMID: 34831445 DOI: 10.3390/cells10113223] [Reference Citation Analysis]
13 Hashmi AA, Iftikhar SN, Munawar S, Ahmed O, Yaqeen SR, Asghar IA, Irfan M, Ali J, Edhi MM, Hashmi SK. International Society of Urological Pathology (ISUP)-Grade Grouping in Prostatic Adenocarcinoma and its Prognostic Implications. Cancer Invest 2021;:1-8. [PMID: 34907822 DOI: 10.1080/07357907.2021.2019263] [Reference Citation Analysis]
14 Purohit S, Bhaladhare S, Marathe N, Shah S, Raj A. Small Cell Prostate Cancer with Atypical Presentation -A Case Report and Review of Literature. J Orthop Case Rep 2020;10:50-3. [PMID: 32953655 DOI: 10.13107/jocr.2020.v10.i02.1692] [Reference Citation Analysis]